TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9168439

Group type: EXPERIMENTAL
Intervention: lenograstim 5 micrograms/kg/day (n = 82)
Number of subjects: 162

Group type: COMPARATOR
Intervention: placebo (n = 80)
Number of subjects: 162
Study: 8460344

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) vaccination of recombinant HB vaccine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Intradermal (ID) vaccination of recombinant HB vaccine
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: IM booster dose given 10 months after the third injection
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Age > 30 years
Number of subjects: 83
Study: 3895410

Group type: EXPERIMENTAL
Intervention: Emepronium carrageenate (EC) 500 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Emepronium carrageenate (EC) 1000 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Emepronium carrageenate (EC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30823909

Group type: EXPERIMENTAL
Intervention: Digital lifestyle intervention
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Digital and face-to-face group lifestyle intervention
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 3000
Study: 29533946

Group type: EXPERIMENTAL
Intervention: Revascularization (successful revascularization)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Low baseline ADCr (<64%) with successful revascularization
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Revascularization (flow reconstitution)
Number of subjects: 65
Study: 27173472

Group type: EXPERIMENTAL
Intervention: Weight loss program
Number of subjects: 143
Study: 24950995

Group type: EXPERIMENTAL
Intervention: Augmented feedback intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 21783298

Group type: EXPERIMENTAL
Intervention: 15 mg of meloxicam IM
Number of subjects: 30

Group type: COMPARATOR
Intervention: 50 mg of tramadol IM
Number of subjects: 30
Study: 20738456

Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine/herbal extract combination
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.1% chlorhexidine solution
Number of subjects: 45
Study: 18031323

Group type: EXPERIMENTAL
Intervention: High-carbohydrate meal (CHO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-fat meal (FAT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Continued fast (FAST)
Number of subjects: 10
Study: 16953808

Group type: EXPERIMENTAL
Intervention: Multi-component fall-prevention efforts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depression screening and treatment
Number of subjects: 0
Study: 14971519

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination at a dose of 0.1 ml, 2 microg, administered at 5 positions, 4 vaccinations at months 0, 1, 2, and 6 (M0, M1, M2, M6)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Intramuscular vaccination at a dose of 1.0 ml, 20 microg, administered at 2 positions, 4 vaccinations at months 0, 1, 2, and 6 (M0, M1, M2, M6)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination
Number of subjects: 2

Group type: COMPARATOR
Intervention: Intramuscular vaccination
Number of subjects: 2
Study: 10812328

Group type: EXPERIMENTAL
Intervention: Vitamin E intervention in the prevention of cataract and age-related maculopathy
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Electoral roll mail-out
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Newspaper advertising
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Radio advertising, approaches to community groups, approaches via general practices
Number of subjects: 1204
Study: 8712886

Group type: EXPERIMENTAL
Intervention: IA guanethidine 20 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: IA saline (placebo)
Number of subjects: 18
Study: 31721892

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 195

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 195

Group type: COMPARATOR
Intervention: tDCS vs. placebo
Number of subjects: 195

Group type: COMPARATOR
Intervention: tDCS vs. escitalopram
Number of subjects: 195

Group type: COMPARATOR
Intervention: escitalopram vs. placebo
Number of subjects: 195
Study: 29443905

Group type: EXPERIMENTAL
Intervention: Military body armour (MBA: 6.4 kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Law-enforcement body armour (LEBA: 2.1 kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both body armours
Number of subjects: 10
Study: 29071931

Group type: EXPERIMENTAL
Intervention: Acupuncture + fire dragon moxibustion
Number of subjects: 90

Group type: COMPARATOR
Intervention: Acupuncture (control)
Number of subjects: 90
Study: 24122481

Group type: EXPERIMENTAL
Intervention: Media Heroes cyberbullying prevention program
Number of subjects: 593

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 593
Study: 22337211

Group type: EXPERIMENTAL
Intervention: Physical therapy (education, muscle stretching, exercises, homework for nine treatments in 6 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (education on evaluation days only)
Number of subjects: 53
Study: 22184305

Group type: EXPERIMENTAL
Intervention: Cefazolin (2 g) administered before skin incision
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: Cefazolin (2 g) administered after umbilical cord clamping
Number of subjects: 1112

Group type: COMPARATOR
Intervention: Placebo administered before skin incision
Number of subjects: 1112
Study: 17971285

Group type: EXPERIMENTAL
Intervention: Risedronate 150 mg (50 mg doses on 3 consecutive days) monthly for 6 months
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Loading dose of risedronate 15 mg daily for 1 month followed by 150 mg (50 mg doses on 3 consecutive days) monthly for 5 months
Number of subjects: 150

Group type: COMPARATOR
Intervention: Risedronate 5 mg daily for 6 months
Number of subjects: 150
Study: 16145231

Group type: EXPERIMENTAL
Intervention: Clo‐Sur PAD nonwoven hydrophilic wound dressing (HWD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: RadiStop compression device (CD)
Number of subjects: 80
Study: 11865830

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PXF) 1800 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10539744

Group type: EXPERIMENTAL
Intervention: Solid-food diet (SFD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Liquid-formula diet (LFD)
Number of subjects: 21
Study: 7592212

Group type: EXPERIMENTAL
Intervention: Inhaled methacholine (intervention)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Raw (1.3), RLq (1.4), RL of double resting frequency (1.9), Rrs (1.7), smooth curve fit of Pm back extrapolated to valve closure (1.5) (baseline measurements)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rint methods (three methods of obtaining Rint)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rrs methods
Number of subjects: 7
Study: 2089148

Group type: EXPERIMENTAL
Intervention: Flex-Foot
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Carbon Copy II
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: SEATTLE
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: STEN
Number of subjects: 5

Group type: COMPARATOR
Intervention: SACH foot
Number of subjects: 5
Study: 105689

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 23
Study: 30383229

Group type: EXPERIMENTAL
Intervention: Acute weight loss (mean, 7.2%)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lean control group (n = 80)
Number of subjects: 80
Study: 26648167

Group type: EXPERIMENTAL
Intervention: Female offenders with mental retardation
Number of subjects: 156

Group type: COMPARATOR
Intervention: Male offenders with mental retardation
Number of subjects: 156

Group type: COMPARATOR
Intervention: General assessment of severe mental disorder
Number of subjects: 156
Study: 25554550

Group type: EXPERIMENTAL
Intervention: Baseline body temperature (mean 37.5°C, SD 1.1°C)
Number of subjects: 969

Group type: EXPERIMENTAL
Intervention: Temperature groups (divided into 5 groups)
Number of subjects: 969
Study: 23458204

Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 21629249

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 3819

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3819
Study: 19520613

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg per day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 16918855

Group type: EXPERIMENTAL
Intervention: Healthy Learners Asthma Initiative (HLAI) intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 15327408

Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin concentration (Hb) stratified by quartile: first quartile <11.3 g/dL
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin concentration (Hb) stratified by quartile: second quartile 11.3 to 12.5 g/dL
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin concentration (Hb) stratified by quartile: third quartile 12.6 to 13.8 g/dL
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: Hemoglobin as a continuous variable
Number of subjects: 1513
Study: 11154169

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lansoprazole or Omeprazole with antibiotics
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Serology monitoring
Number of subjects: 50
Study: 9286194

Group type: EXPERIMENTAL
Intervention: Assertive community treatment
Number of subjects: 77
Study: 8403909

Group type: EXPERIMENTAL
Intervention: NORPLANT II contraceptive implant
Number of subjects: 1466
Study: 3520426

Group type: EXPERIMENTAL
Intervention: Monthly maintenance therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Special type of immunotherapy
Number of subjects: 0
Study: 29370744

Group type: EXPERIMENTAL
Intervention: IT-enabled intervention (website development, SMS, e-mail reminders, interactive help by mobile and landline phones)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional nutrition education program (distributing pamphlets)
Number of subjects: 0
Study: 27774073

Group type: EXPERIMENTAL
Intervention: Group music therapy plus standard care (48 weekly sessions of 2 hours)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 27
Study: 25596790

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound guidance
Number of subjects: 698

Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 698
Study: 22961006

Group type: EXPERIMENTAL
Intervention: Enteral supplementation of scGOS/lcFOS/pAOS
Number of subjects: 113

Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 113
Study: 20862947

Group type: EXPERIMENTAL
Intervention: Acupuncture RCTs in China
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acupuncture RCTs in the United States
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture RCTs
Number of subjects: 0
Study: 19081527

Group type: EXPERIMENTAL
Intervention: Infliximab induction (5 mg/kg/dose) at weeks 0, 2, and 6; maintenance therapy every 8 or 12 weeks
Number of subjects: 112
Study: 16093871

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg on demand for 6 months
Number of subjects: 536

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 536
Study: 11870412

Group type: EXPERIMENTAL
Intervention: Orocal D3 (500 mg Ca and 400 IU vitamin D) taken in two doses 6 hours apart
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cacit D3 (1000 mg Ca and 880 IU vitamin D) taken as a single morning dose
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no drug intake)
Number of subjects: 12
Study: 10408075

Group type: EXPERIMENTAL
Intervention: Cardiotocography
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (paired cases without cord complications)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Intraobserver variability
Number of subjects: 25
Study: 7584524

Group type: COMPARATOR
Intervention: Clonidine (0.3 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moxonidine (0.3 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg i.v.)
Number of subjects: 12
Study: 2248350

Group type: EXPERIMENTAL
Intervention: Verbal cues
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Visual cues
Number of subjects: 28

Group type: COMPARATOR
Intervention: Uncued test
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cued test
Number of subjects: 28
Study: 7011226

Group type: EXPERIMENTAL
Intervention: Aspirin (1,300 mg daily) and dipyridamole (100 mg daily)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups (IMA-LAD grafts)
Number of subjects: 113
Study: 30736832

Group type: EXPERIMENTAL
Intervention: Aerobic-based exercise intervention (thrice-weekly, moderate-intensity aerobic exercise supplemented with isometric resistance exercise)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Aerobic-based exercise intervention
Number of subjects: 160
Study: 30953791

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 50% maximum inspiratory pressure (MIP) for 4 weeks, 30 breaths twice daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for smokers
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo group (15% MIP for 4 weeks, 30 breaths twice daily)
Number of subjects: 42
Study: 28350830

Group type: EXPERIMENTAL
Intervention: MVPA intervention (n = 10 SDCs)
Number of subjects: 1830

Group type: COMPARATOR
Intervention: Healthy eating attention control (n = 10 SDCs)
Number of subjects: 1830
Study: 25307931

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Ustekinumab (with dosing adjustments)
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Ustekinumab (overall treatment)
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Ustekinumab (safety profile)
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1212
Study: 24046302

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 2495
Study: 21898590

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneously every 6 months for 3 years)
Number of subjects: 1468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1468
Study: 18061174

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gonadotropins
Number of subjects: 0
Study: 16864821

Group type: EXPERIMENTAL
Intervention: Activity-dependent conduction block (ADCB) test after 1 minute of maximal voluntary contraction (magnetic fatigue test)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: IV immunoglobulins (IVIgs)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Duration from the onset to the positive peak of the CMAP
Number of subjects: 9
Study: 12458383

Group type: EXPERIMENTAL
Intervention: Glucomannan + rifaximin (400 mg twice daily for 7 days every month)
Number of subjects: 968

Group type: COMPARATOR
Intervention: Glucomannan alone (4 g/day)
Number of subjects: 968
Study: 11148445

Group type: EXPERIMENTAL
Intervention: Oral mesalazine 4 g
Number of subjects: 130

Group type: COMPARATOR
Intervention: Combined mesalazine 2 g orally plus 2 g rectally as a liquid enema
Number of subjects: 130
Study: 9106834

Group type: EXPERIMENTAL
Intervention: Elated mood induction (film fragments expressing happiness and euphoria)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Depressed mood induction (frightening and distressing film fragments)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neutral mood induction (no film)
Number of subjects: 60
Study: 7687443

Group type: EXPERIMENTAL
Intervention: 3H-spiperone binding in patients with PD not treated with L-DOPA
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 3H-spiperone binding in parkinsonian patients with PD treated with L-DOPA
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 3H-spiperone binding in patients with essential tremor
Number of subjects: 123

Group type: COMPARATOR
Intervention: 3H-spiperone binding in healthy control persons
Number of subjects: 123
Study: 3576156

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with 1-2% carbonated lidocaine
Number of subjects: 1000

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1000
Study: 29182402

Group type: EXPERIMENTAL
Intervention: Individual performance
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Team performance
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Team process quality
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Teams with highly engaged recorders
Number of subjects: 5
Study: 26643072

Group type: EXPERIMENTAL
Intervention: RESTORE web-based intervention
Number of subjects: 163

Group type: COMPARATOR
Intervention: Leaflet (control group)
Number of subjects: 163
Study: 24461045

Group type: EXPERIMENTAL
Intervention: Established lifestyle intervention
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Insulin use during pregnancy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Barriers to participation
Number of subjects: 43
Study: 22489521

Group type: EXPERIMENTAL
Intervention: Plaster splint of U‐shape to the posture with inversion, internal rotation and plantar flexion (Group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Plaster splint of U‐shape to the posture with inversion, internal rotation and dorsiflexion (Group B)
Number of subjects: 46
Study: 20956792

Group type: EXPERIMENTAL
Intervention: H-coil rTMS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: C-coil rTMS
Number of subjects: 12

Group type: COMPARATOR
Intervention: S-coil rTMS
Number of subjects: 12
Study: 18082889

Group type: EXPERIMENTAL
Intervention: Long-term IOP fluctuation (measured as standard deviation of IOP)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Mean IOP
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Low mean IOP group
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: High mean IOP group
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Lower and upper terciles of IOP fluctuation
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Mean IOP and IOP fluctuation correlation
Number of subjects: 301
Study: 17162239

Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 15316
Study: 14620304

Group type: EXPERIMENTAL
Intervention: Segmental acupuncture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Heterosegmental superficial acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (standard treatment only, regional inferior dental block)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Segmental acupuncture vs Heterosegmental superficial acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Segmental acupuncture vs Control
Number of subjects: 30

Group type: COMPARATOR
Intervention: Heterosegmental superficial acupuncture vs Control
Number of subjects: 30
Study: 10648334

Group type: EXPERIMENTAL
Intervention: Acetaminophen 20 mg/kg (AS)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Acetaminophen 40 mg/kg (AL)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Acetaminophen 20 mg/kg + Diclofenac 100 mg (C)
Number of subjects: 65
Study: 8660161

Group type: EXPERIMENTAL
Intervention: Centralized grading of fundus photographs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinical evaluation at participating centers
Number of subjects: 0
Study: 2916452

Group type: EXPERIMENTAL
Intervention: 800-kcal/d liquid diet with 6% of calories as LCT and 24% as MCT (group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 800-kcal/d liquid diet with 30% of calories as LCT (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (MCT and LCT)
Number of subjects: 0
Study: 12850

Group type: EXPERIMENTAL
Intervention: Atenolol 150 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atenolol 300 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methyldopa 750 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methyldopa 1500 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atenolol 150 mg/day and Methyldopa 750 mg/day (combined treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methyldopa (lower dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atenolol (lower dose)
Number of subjects: 0
Study: 31383238

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy (SRT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE)
Number of subjects: 150
Study: 28778047

Group type: EXPERIMENTAL
Intervention: Metformin (1g, b.i.d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Rosiglitazone (4mg, b.i.d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Metformin in rats
Number of subjects: 41
Study: 26303628

Group type: EXPERIMENTAL
Intervention: Augmented PHILOS plates
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non-augmented PHILOS plates
Number of subjects: 6
Study: 23746615

Group type: EXPERIMENTAL
Intervention: Auditory-based cognitive training (AT) plus social-cognition training (SCT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-specific computer games (CG)
Number of subjects: 22
Study: 22019970

Group type: EXPERIMENTAL
Intervention: Simple needling
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Modified acupuncture (AcP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo control (sham AcP)
Number of subjects: 45
Study: 19334068

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m², four weekly infusions)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 26
Study: 22965186

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 17922